D. Hawerlander

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

R. Salamon, H. Ahiboh, C. Rouzioux, 2015, The New England journal of medicine.

Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study

G. Gottlieb, C. Adebamowo, A. Sasco, 2013, PloS one.

Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of The West African Database to evaluate AIDS collaboration

D. Minta, F. Dabis, D. Ekouevi, 2014, Journal of the International AIDS Society.

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.

R. Salamon, C. Rouzioux, S. Eholie, 2017, The Lancet. Global health.

Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low‐ and middle‐income countries

M. Yotebieng, L. Diero, T. Sterling, 2019, Journal of the International AIDS Society.

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

G. Gottlieb, J. Stringer, C. Yiannoutsos, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Incidence of Tuberculosis During the First Year of Antiretroviral Treatment in West African HIV-Infected Adults

F. Dabis, E. Balestre, A. Minga, 2020, Open forum infectious diseases.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

R. Salamon, H. Ahiboh, C. Rouzioux, 2015, The New England journal of medicine.

Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium

L. Diero, F. Dabis, F. Palella, 2022, Journal of the International AIDS Society.